T2 Biosystems Inc (TTOO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

101 HARTWELL AVENUE LEXINGTON, MA 02421

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.

Data as of 2021-08-02 08:41:37 -0400
Market Cap154.611 Million Shares Outstanding150.108 Million Avg 30-day Volume2.598 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE0.04 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.22615 52-week High/Low3.79 / 1.0 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -16.5763
Data provided by IEX Cloud
View SEC Filings from TTOO instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 82 68 20.59% 18 (1.06%) 16 (0.93%) 12.5%
13F shares: 26.29 Million 21.437 Million 22.64% 6.705 Million 3.44 Million 94.89%
% Ownership 17.7688 14.4885 22.64% 4.5318 2.3253 94.89%
New Positions: 27 20 35.0% 6 6 0.0%
Increased Positions 23 19 21.05% 5 4 25.0%
Closed Positions 10 10 0.0% 3 3 0.0%
Reduced Positions 18 11 63.64% 6 3 100.0%
Total Calls 716.379 Thousand 263.562 Thousand 171.81% 150.5 Thousand 132.1 Thousand 13.93%
Total Puts 554.803 Thousand 230.592 Thousand 140.6% 254.9 Thousand 45.4 Thousand 461.45%
PUT/CALL Ratio 0.77 0.87 -11.49% 1.69 0.34 397.06%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TTOO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TTOO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

36.4 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

181.8 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CUMMING JOHN W

  • Director
50,852 2021-07-01 3

MCDONOUGH JOHN

  • Director
516,386 2021-07-01 3

ELSBREE DAVID B

  • Director
253,947 2021-06-25 3

LIEBMAN SEYMOUR

  • Director
248,317 2021-06-25 3

TOFT ROBIN

  • Director
73,224 2021-06-25 3

SAUNDERS NINFA

  • Director
73,224 2021-06-25 3

BERNARD THIERRY

  • Director
73,224 2021-06-25 3

GIBBS MICHAEL TERRENCE GENERAL COUNSEL

  • Officer
188,603 2021-03-24 3

BARCLAY ALEC CHIEF OPERATIONS OFFICER

  • Officer
74,420 2021-03-17 4

PARE ANTHONY CHIEF COMMERCIAL OFFICER

  • Officer
31,612 2021-03-17 3

SPRAGUE JOHN M CHIEF FINANCIAL OFFICER

  • Officer
437,158 2021-02-24 2

SPERZEL JOHN J III SEE REMARKS

  • Officer
  • Director
1,693,989 2021-02-24 2

AHUJA APARNA CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-05 2

GOLDMAN SACHS & CO. LLC

GOLDMAN SACHS GROUP INC

  • 10% Owner
4,201,582 2020-03-24 0

JONES ADRIAN M

  • Director
4,201,582 2020-03-24 0

LOWERY THOMAS J. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-03-14 0

CIMA MICHAEL J.

  • Director
213,178 2019-06-11 0

LAPIDUS STANLEY

  • Director
53,010 2019-06-11 0

DHANDA RAHUL SVP OF CORPORATE DEVELOPMENT

  • Officer
5,667 2017-06-06 0

SPADORO JOANNE CHIEF OPERATIONS OFFICER

  • Officer
5,589 2017-06-06 0

DEPTULA-HICKS DARLENE M SVP & CHIEF FINANCIAL OFFICER

  • Officer
4,000 2017-06-06 0

HARDING DAVID CHIEF COMMERCIAL OFFICER

  • Officer
0 2017-02-09 0

LYNCH SHAWN CHIEF FINANCIAL OFFICER

  • Officer
0 2017-02-09 0

CANON U.S.A., INC.

CANON INC

  • 10% Owner
6,055,341 2016-09-21 0

BILENKER JOSHUA H.

  • Director
0 2016-06-17 0

WILCOX HARRY W

  • Director
0 2016-06-17 0

PFALLER MICHAEL A. CHIEF MEDICAL OFFICER

  • Officer
0 2016-01-20 0

KALIL SARAH O. CHIEF OPERATING OFFICER

  • Officer
0 2016-01-20 0

AISLING CAPITAL III LP

AISLING CAPITAL PARTNERS III LP

AISLING CAPITAL PARTNERS III LLC

ELMS STEVE

SCHIFF ANDREW N

PURCELL DENNIS J

  • Director
  • 10% Owner
2,830,992 2015-12-09 0

CARELLA THOMAS J.

4,157,240 2015-12-09 0

MBD ADVISORS, L.L.C.

4,157,240 2015-12-09 0

GOLDMAN SACHS GROUP INC

GOLDMAN SACHS & CO

BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.

BRIDGE STREET 2013 HOLDINGS, L.P.

BRIDGE STREET 2013 OFFSHORE, L.P.

BRIDGE STREET 2013, L.P.

BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.

MBD 2013 HOLDINGS, L.P.

MBD 2013, L.P.

MBD 2013 OFFSHORE, L.P.

4,157,240 2015-12-09 0

CASTONGUAY MAURICE L CHIEF FINANCIAL OFFICER

  • Officer
0 2015-08-06 0

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

  • 10% Owner
2,206,723 2015-08-05 0

LAPIDUS STANLEY N

  • Director
0 2015-06-19 0

FLAGSHIP VENTURES FUND 2004 L P

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

AFEYAN NOUBAR

KANIA EDWIN M JR

  • 10% Owner
2,374,571 2014-08-12 0

CRANE ALAN L

  • Director
30,000 2014-08-12 0

CRANE ALAN L

POLARIS VENTURE PARTNERS V, L.P.

POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

  • Director
  • 10% Owner
0 2014-08-06 0

JONES MARC R. CHIEF FINANCIAL OFFICER

  • Officer
0 2014-08-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CUMMING JOHN W - Director

2021-07-02 16:00:17 -0400 2021-07-01 S 18,182 $1.16 d 50,852 direct yes -2.7523 -3.6697 3.6697 4 -3.6697 6

MCDONOUGH JOHN - Director

2021-07-02 16:00:23 -0400 2021-07-01 S 18,182 $1.16 d 516,386 direct yes -2.7523 -3.6697 3.6697 4 -3.6697 6

TOFT ROBIN - Director

2021-06-29 14:55:16 -0400 2021-06-25 A 73,224 a 73,224 direct

SAUNDERS NINFA - Director

2021-06-29 15:01:43 -0400 2021-06-25 A 73,224 a 73,224 direct

LIEBMAN SEYMOUR - Director

2021-06-29 14:59:57 -0400 2021-06-25 M 45,454 a 129,639 direct -3.252 -13.8211 0.0 1 -13.8211 6

CUMMING JOHN W - Director

2021-06-29 15:00:33 -0400 2021-06-25 M 45,454 d 45,454 direct

ELSBREE DAVID B - Director

2021-06-29 14:56:14 -0400 2021-06-25 M 45,454 d 45,454 direct

MCDONOUGH JOHN - Director

2021-06-29 14:56:47 -0400 2021-06-25 M 45,454 d 45,454 direct

LIEBMAN SEYMOUR - Director

2021-06-29 14:59:57 -0400 2021-06-25 A 73,224 a 73,224 direct

BERNARD THIERRY - Director

2021-06-29 15:00:10 -0400 2021-06-25 A 73,224 a 73,224 direct

CUMMING JOHN W - Director

2021-06-29 15:00:33 -0400 2021-06-25 M 45,454 a 69,034 direct -3.252 -13.8211 0.0 1 -13.8211 6

ELSBREE DAVID B - Director

2021-06-29 14:56:14 -0400 2021-06-25 M 45,454 a 170,723 direct -3.252 -13.8211 0.0 1 -13.8211 6

MCDONOUGH JOHN - Director

2021-06-29 14:56:47 -0400 2021-06-25 M 45,454 a 534,568 direct -3.252 -13.8211 0.0 1 -13.8211 6

LIEBMAN SEYMOUR - Director

2021-06-29 14:59:57 -0400 2021-06-25 M 45,454 d 45,454 direct

CUMMING JOHN W - Director

2021-06-29 15:00:33 -0400 2021-06-25 A 81,967 a 81,967 direct

ELSBREE DAVID B - Director

2021-06-29 14:56:14 -0400 2021-06-25 A 73,224 a 73,224 direct

MCDONOUGH JOHN - Director

2021-06-29 14:56:47 -0400 2021-06-25 A 81,967 a 81,967 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
T2 BIOSYSTEMS INC TTOO 2021-08-05 22:15:04 UTC -1.2024 1.2824 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 21:45:03 UTC -1.2009 1.2809 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 21:15:03 UTC -1.2009 1.2809 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 20:45:03 UTC -1.1964 1.2764 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 20:15:04 UTC -1.1964 1.2764 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 19:45:04 UTC -1.1964 1.2764 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 19:15:03 UTC -1.1964 1.2764 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 18:45:03 UTC -1.2051 1.2851 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 18:15:03 UTC -1.2051 1.2851 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 17:45:03 UTC -1.2051 1.2851 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 17:15:03 UTC -1.2051 1.2851 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 16:45:02 UTC -1.2447 1.3247 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 16:15:03 UTC -1.2447 1.3247 3800000
T2 BIOSYSTEMS INC TTOO 2021-08-05 15:45:03 UTC -1.2447 1.3247 3900000
T2 BIOSYSTEMS INC TTOO 2021-08-05 15:15:02 UTC -1.2447 1.3247 4100000
T2 BIOSYSTEMS INC TTOO 2021-08-05 14:45:02 UTC -1.0028 1.0828 4100000
T2 BIOSYSTEMS INC TTOO 2021-08-05 14:15:04 UTC -1.0028 1.0828 4200000
T2 BIOSYSTEMS INC TTOO 2021-08-05 13:45:04 UTC -1.0028 1.0828 4200000
T2 BIOSYSTEMS INC TTOO 2021-08-05 13:15:03 UTC -1.0028 1.0828 4200000
T2 BIOSYSTEMS INC TTOO 2021-08-05 12:45:03 UTC -1.0028 1.0828 4100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments